Clinical heterogeneity and outcomes of antisynthetase syndrome. - Wikidata - awgldk - TriplyDB

Clinical heterogeneity and outcomes of antisynthetase syndrome.

Clinical heterogeneity and outcomes of antisynthetase syndrome.

http://www.wikidata.org/entity/Q38116464

about

Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study Mechanic's hands in a woman with undifferentiated connective tissue disease and interstitial lung disease--anti-PL7 positive antisynthetase syndrome: a case report.Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.

P2860

Q28395250-D5C382DC-7FD0-4093-B574-BCD56035761D Q30251952-80E17799-5F74-4126-9BEB-83C70AC9FB34 Q35195954-3E63AA84-F045-44CD-B6F3-1C6004EE60AF Q35530273-1E1DEE6C-E817-4E61-886B-2C95EE3FBDBA Q36195131-DA2C7B88-4885-42AA-BC14-9A0BBEA32B36 Q37674765-832D8611-83B8-4E4F-93B6-823DFE597AC7 Q39501862-168B26F2-8F71-43AE-B6B9-30155D0D7E7C Q41538311-875F335D-972F-4C80-9C69-CD3E3AFE043F Q53790402-A5460BEA-57C8-4EE8-8BEF-DCCE94CB0706

P2860

Clinical heterogeneity and outcomes of antisynthetase syndrome.

http://www.wikidata.org/entity/Q38116464

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical heterogeneity and outcomes of antisynthetase syndrome.

@en

type

label

Clinical heterogeneity and outcomes of antisynthetase syndrome.

@en

prefLabel

Clinical heterogeneity and outcomes of antisynthetase syndrome.

@en

P1433

Q38116464-1C1AD33C-DC06-432B-968A-F6132EFCE822

P1476

Q38116464-7033AC8C-4B32-42FA-80DB-9E7B45268166

P2093

Q38116464-0194DB6B-AF9E-4B56-ACCF-4A3C51945A9A

Q38116464-2D4E07C0-630E-4086-B6F7-E2FE2E926FD9

P2860

Q38116464-015809F2-271E-4FCC-A6B1-7B06E706EB91

Q38116464-0ADB0276-5B6A-4D54-A846-D53115DCE121

Q38116464-10FB14D3-1320-4D48-90BD-4D8A8CCDDD01

Q38116464-1FDD2028-C8A8-4E4C-B8AB-6DEF1FEA96CE

Q38116464-2297015A-44DA-432D-A458-277863571E27

Q38116464-30D71EEC-D88A-4A25-9631-CAB1FE64075F

Q38116464-33518DDB-E193-4E68-98D1-31785659FCDF

Q38116464-3742B4BB-5339-4F43-85CB-A55BD4AF6A8E

Q38116464-3C80B020-4B97-40B2-83C4-A7C1288C8C94

Q38116464-3D5762F2-4143-48F1-9864-28CF0B37A3AF

P2888

Q38116464-E6BE31D0-71F5-42DC-83CB-9877FECFA53B

P304

Q38116464-183F3D50-D219-4322-87CC-C87C5B989E27

P31

Q38116464-91F3EC3E-3460-41F4-83F9-965C38B2CE9E

P356

Q38116464-E65CEFDD-06DA-4C88-BC39-2DB2F3B4F1E0

P433

Q38116464-17BB3C1C-5BEB-44BA-9273-F508C85F19C8

P478

Q38116464-AF42A577-B9EC-40AF-AE41-B1F34DD83A10

P577

Q38116464-761A003E-D8BA-4242-BD5A-3DAB76B8157A

P6179

Q38116464-FCDE769C-9B7A-4D8B-96E2-9CF2497134E2

P698

Q38116464-049BBC5D-D338-48DA-B577-76EF15A14305

P356

S11926-013-0349-8

P1433

Current Rheumatology Reports

P1476

Clinical heterogeneity and outcomes of antisynthetase syndrome.

@en

P2093

Baptiste Hervier

http://www.w3.org/2001/XMLSchema#string

Olivier Benveniste

http://www.w3.org/2001/XMLSchema#string

P2860

Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis

Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.

Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia.

Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations.

Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases.

Morbidity and mortality in adult polymyositis and dermatomyositis.

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

P2888

s11926-013-0349-8

P304

349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-013-0349-8

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021161066

http://www.w3.org/2001/XMLSchema#string

P698

23794106

http://www.w3.org/2001/XMLSchema#string